The ASX has communicated to all market participants of an industry-wide ASX settlement failure that occurred on Friday the 20th of December. This failure has meant that CHESS was not able to complete market settlement on Friday and has deferred settlement to Monday the 23rd of December. For those clients who had sell trades settling on Friday we have ensured those sale proceeds have been made available to you for trading on Monday. Stock delivery for clients who had buy trades settling will need to wait until Monday before the shares become available to sell. We apologise for any inconvenience this ASX outage has caused.
Reporting Season - 23 August
Companies covered: Inghams Group (ING), Telix Pharmaceutical (TLX), Accent Group (AX1)
Stocks discussed:
- Inghams Group (ING): FY profit jumps as revenue climbs 7% but warns of challenging conditions ahead as consumers feel the pinch of cost-of-living pressures
- Telix Pharmaceuticals (TLX): HY net profit of $29.7 million, from a net loss last year, with revenue up 65% and reaffirms FY 2024 guidance
- Accent Group (AX1): 33% net loss in net profit after tax, sales rise but reiterates a challenging consumer environment, with a final fully franked dividend of $0.13/share